Pros and Cons of Filtrona plc in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Filtrona plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Filtrona plc | 0.000% | 12.727% | 34.783% | 3.333% | 12.727% | -32.609% | -62.424% |
| Universal Corp. | -0.650% | -0.216% | 1.226% | -3.466% | 2.528% | 2.984% | 5.234% |
| Japan Tobacco Inc | 2.100% | 8.697% | 14.533% | 46.546% | 20.402% | 84.585% | 122.275% |
| Nichols plc | -0.840% | 5.310% | 10.185% | -22.727% | 11.215% | 0.000% | -25.625% |
Comments
Essentra (FLRAF) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Show more
Ratings data for FLRAF provided by MarketBeat
Essentra plc (OTCMKTS: FLRAF) had its "buy" rating re-affirmed by analysts at Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for FLRAF provided by MarketBeat
Essentra plc (OTCMKTS: FLRAF) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating on the stock.
Show more
Ratings data for FLRAF provided by MarketBeat
News
Essentra H1 Earnings Call Highlights
Essentra (LON:ESNT) reported first-half revenue growth of 9% to £166 million, supported by a roughly even contribution from volume growth and pricing, while adjusted operating profit rose 9.7% to
